Inhibition of Endotoxin Response by E5564, a Novel Toll-Like Receptor 4-Directed Endotoxin Antagonist-Reference-Cited by-同舟云学术

Inhibition of Endotoxin Response by E5564, a Novel Toll-Like Receptor 4-Directed Endotoxin Antagonist

Published:2002-11-25 Issue:3 Volume:304 Page:1093-1102
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Mullarkey Maureen,Rose Jeffrey R.,Bristol John,Kawata Tsutomu,Kimura Akufumi,Kobayashi Seiichi,Przetak Melinda,Chow Jesse,Gusovsky Fabian,Christ William J.,Rossignol Daniel P.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference40 articles.

1. A Critical Evaluation of New Agents for the Treatment of Sepsis

2. Gram-Negative Sepsis

3. Neisseria meningitidis lipopolysaccharides in human pathology

4. Human responses to bacterial endotoxin.;Burrell;Circ Shock,1994

5. Toll-like Receptor-4 Mediates Lipopolysaccharide-induced Signal Transduction

Cited by 273 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimization of a Lethal, Combat-Relevant Model of Sterile Inflammation in Mice for Drug Candidate Screening;Military Medicine;2024-08-19

2. The emerging role of adaptor proteins in regulating innate immunity of sepsis;Pharmacological Research;2024-07

3. Acute Kidney Injury: Definition, Management, and Promising Therapeutic Target;Cureus;2023-12-28

4. Rosacea pathogenesis and therapeutics: current treatments and a look at future targets;Frontiers in Medicine;2023-12-13

5. Bacillus coagulans MZY531 alleviates intestinal mucosal injury in immunosuppressive mice via modulating intestinal barrier, inflammatory response, and gut microbiota;Scientific Reports;2023-07-10